SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-100292
Filing Date
2021-03-30
Accepted
2021-03-30 16:48:02
Documents
3
Period of Report
2021-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d108142d8k.htm 8-K 25249
2 EX-3.1 d108142dex31.htm EX-3.1 29333
3 EX-3.2 d108142dex32.htm EX-3.2 100778
  Complete submission text file 0001193125-21-100292.txt   156646
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40287 | Film No.: 21786716
SIC: 2836 Biological Products, (No Diagnostic Substances)